Fitness and nutrition gurus like to make weight loss sound easy. But in reality, it’s often incredibly tough to incorporate ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

In one study, up to 50% of patients experienced gastrointestinal issues and other adverse effects after taking a 15-mg dose of tirzepatide. Many families have filed lawsuits against the makers of ...

with some insurers reluctant to cover them simply for weight loss. In the 731-patient SUMMIT study, participants were randomly assigned to either tirzepatide at a dose of between 2.5mg and 15mg ...

Lange explained on a conference call that one reason for the miss was a flexible treatment protocol that allowed patients to ...

Eli Lilly posts robust Q4 earnings as Mounjaro and Zepbound sales more than double, lifting full-year revenue by 32% ...

lipid disorders and obesity in the FDA’s Center for Drug Evaluation and Research, said in a news release. “While it is not known if the impact on blood pressure was due to the medication or the ...

Trusted source of information on diabetes that includes articles, news, videos, animations, quizzes, calculators and drugs.

This drug is also used as a treatment option ... to high in terms of efficacy in lowering blood sugar. For weight loss, SGLT2 inhibitors are ranked as intermediate in efficacy. They rank higher than ...

Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss KELOWNA, BC / ACCESS Newswire / February 5, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "L ...